292 filings
Page 2 of 15
4
Christine Bellon
5 Jan 24
Beam Therapeutics / Christine Bellon ownership change
4:30pm
4
BEAM
Beam Therapeutics Inc
27 Dec 23
Change in insider ownership
10:56am
4
BEAM
Beam Therapeutics Inc
14 Dec 23
Beam Therapeutics / Christi Shaw ownership change
4:15pm
3
BEAM
Beam Therapeutics Inc
14 Dec 23
Beam Therapeutics / Christi Shaw ownership change
4:10pm
8-K
BEAM
Beam Therapeutics Inc
14 Dec 23
Beam Therapeutics Appoints Biotech Executive Christi Shaw to its Board of Directors
4:05pm
4
Christine Bellon
22 Nov 23
Beam Therapeutics / Christine Bellon ownership change
4:05pm
144
BEAM
Beam Therapeutics Inc
20 Nov 23
Notice of proposed sale of securities
4:20pm
10-Q
2023 Q3
BEAM
Beam Therapeutics Inc
Quarterly report
8 Nov 23
7:30am
8-K
BEAM
Beam Therapeutics Inc
8 Nov 23
Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results
7:00am
4
BEAM
Beam Therapeutics Inc
1 Nov 23
Beam Therapeutics / Amy Simon ownership change
4:30pm
8-K
BEAM
Beam Therapeutics Inc
31 Oct 23
Beam Announces Agreement for Lilly to Acquire Beam’s Opt-In Rights to Verve Therapeutics’ Base Editing Programs for Cardiovascular Disease
6:44am
144
Amy Simon
30 Oct 23
Notice of proposed sale of securities
4:41pm
4
Giuseppe Ciaramella
24 Oct 23
Beam Therapeutics / Giuseppe Ciaramella ownership change
4:05pm
8-K
BEAM
Beam Therapeutics Inc
19 Oct 23
Cost Associated with Exit or Disposal Activities
8:50am
UPLOAD
BEAM
Beam Therapeutics Inc
12 Oct 23
Letter from SEC
12:00am
4
Christine Bellon
4 Oct 23
Beam Therapeutics / Christine Bellon ownership change
4:30pm
SC 13G
BEAM
Beam Therapeutics Inc
22 Sep 23
Beam Therapeutics / Farallon Capital Partners ownership change
3:20pm
CORRESP
BEAM
Beam Therapeutics Inc
20 Sep 23
Correspondence with SEC
12:00am
UPLOAD
BEAM
Beam Therapeutics Inc
22 Aug 23
Letter from SEC
12:00am
4
Amy Simon
9 Aug 23
Beam Therapeutics / Amy Simon ownership change
4:08pm